Annual EBITDA
-$51.22 M
-$18.78 M-57.91%
December 31, 2023
Summary
- As of February 7, 2025, OBIO annual EBITDA is -$51.22 million, with the most recent change of -$18.78 million (-57.91%) on December 31, 2023.
- During the last 3 years, OBIO annual EBITDA has fallen by -$32.60 million (-175.15%).
- OBIO annual EBITDA is now -175.15% below its all-time high of -$18.61 million, reached on December 31, 2020.
Performance
OBIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$16.27 M
+$519.00 K+3.09%
September 30, 2024
Summary
- As of February 7, 2025, OBIO quarterly EBITDA is -$16.27 million, with the most recent change of +$519.00 thousand (+3.09%) on September 30, 2024.
- Over the past year, OBIO quarterly EBITDA has dropped by -$1.81 million (-12.54%).
- OBIO quarterly EBITDA is now -220.20% below its all-time high of -$5.08 million, reached on March 31, 2022.
Performance
OBIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$59.81 M
-$1.81 M-3.13%
September 30, 2024
Summary
- As of February 7, 2025, OBIO TTM EBITDA is -$59.81 million, with the most recent change of -$1.81 million (-3.13%) on September 30, 2024.
- Over the past year, OBIO TTM EBITDA has dropped by -$11.24 million (-23.14%).
- OBIO TTM EBITDA is now -1077.34% below its all-time high of -$5.08 million, reached on March 31, 2022.
Performance
OBIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OBIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.9% | -12.5% | -23.1% |
| 3 y3 years | -175.2% | -66.7% | -84.6% |
| 5 y5 years | -175.2% | -66.7% | -84.6% |
OBIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -133.8% | at low | -220.2% | +3.1% | -1077.3% | at low |
| 5 y | 5-year | -175.2% | at low | -220.2% | +3.1% | -1077.3% | at low |
| alltime | all time | -175.2% | at low | -220.2% | +3.1% | -1077.3% | at low |
Orchestra BioMed Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.27 M(-3.1%) | -$59.81 M(+3.1%) |
| Jun 2024 | - | -$16.79 M(+17.0%) | -$58.00 M(+7.2%) |
| Mar 2024 | - | -$14.35 M(+15.6%) | -$54.09 M(+5.6%) |
| Dec 2023 | -$51.22 M | -$12.41 M(-14.1%) | -$51.22 M(+5.5%) |
| Sep 2023 | - | -$14.45 M(+12.2%) | -$48.57 M(+10.1%) |
| Jun 2023 | - | -$12.88 M(+12.3%) | -$44.13 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$11.47 M(+17.6%) | -$38.80 M(+19.7%) |
| Dec 2022 | -$32.44 M(+48.1%) | -$9.76 M(-2.5%) | -$32.40 M(+43.1%) |
| Sep 2022 | - | -$10.01 M(+32.6%) | -$22.64 M(+79.3%) |
| Jun 2022 | - | -$7.55 M(+48.6%) | -$12.63 M(+148.6%) |
| Mar 2022 | - | -$5.08 M | -$5.08 M |
| Dec 2021 | -$21.91 M(+17.7%) | - | - |
| Dec 2020 | -$18.61 M | - | - |
FAQ
- What is Orchestra BioMed Holdings annual EBITDA?
- What is the all time high annual EBITDA for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual EBITDA year-on-year change?
- What is Orchestra BioMed Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly EBITDA year-on-year change?
- What is Orchestra BioMed Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings TTM EBITDA year-on-year change?
What is Orchestra BioMed Holdings annual EBITDA?
The current annual EBITDA of OBIO is -$51.22 M
What is the all time high annual EBITDA for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual EBITDA is -$18.61 M
What is Orchestra BioMed Holdings annual EBITDA year-on-year change?
Over the past year, OBIO annual EBITDA has changed by -$18.78 M (-57.91%)
What is Orchestra BioMed Holdings quarterly EBITDA?
The current quarterly EBITDA of OBIO is -$16.27 M
What is the all time high quarterly EBITDA for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly EBITDA is -$5.08 M
What is Orchestra BioMed Holdings quarterly EBITDA year-on-year change?
Over the past year, OBIO quarterly EBITDA has changed by -$1.81 M (-12.54%)
What is Orchestra BioMed Holdings TTM EBITDA?
The current TTM EBITDA of OBIO is -$59.81 M
What is the all time high TTM EBITDA for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high TTM EBITDA is -$5.08 M
What is Orchestra BioMed Holdings TTM EBITDA year-on-year change?
Over the past year, OBIO TTM EBITDA has changed by -$11.24 M (-23.14%)